Long-Term Safety and Effectiveness of Canakinumab in Patients with MKD/HIDS: Interim Analysis of the RELIANCE Registry
Rheumatology and Therapy · 2025-02 · 12 (1) · 137-155
DOI: 10.1007/s40744-024-00733-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rheumatology and Therapy, online erschienen am 26.12.2024. Verfasst von Prasad T Oommen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Paediatric Rheumatology, Department of Paediatric Oncology, Haematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-Universi…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Novartis Pharma AG.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Paediatric Rheumatology, Department of Paediatric Oncology, Haematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany. Prasad.Oommen@med.uni-duesseldor…
- Department of Paediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité Universitätsmedizin, Berlin, Germany.
- Deutsches Rheuma-Forschungszentrum (DRFZ), An Institute of the Leibniz Association, Berlin, Germany.
- German Center for Child and Adolescent Health (DZKJ), Partner Site Berlin, Berlin, Germany.
- Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander University (FAU) Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
- DZI (Deutsches Zentrum Für Immuntherapie), Erlangen, Germany.
Förderung
- Novartis Pharma AG
Zitieren
APA
Oommen, P. T., Kallinich, T., Rech, J., Blank, N., Weber-Arden, J., & Kuemmerle-Deschner, J. B. (2025). Long-Term Safety and Effectiveness of Canakinumab in Patients with MKD/HIDS: Interim Analysis of the RELIANCE Registry. Rheumatology and Therapy, 12(1), 137-155. https://doi.org/10.1007/s40744-024-00733-7
Vancouver
Oommen PT, Kallinich T, Rech J, Blank N, Weber-Arden J, Kuemmerle-Deschner JB. Long-Term Safety and Effectiveness of Canakinumab in Patients with MKD/HIDS: Interim Analysis of the RELIANCE Registry. Rheumatology and Therapy. 2025;12(1):137-155. doi:10.1007/s40744-024-00733-7
BibTeX
@article{Oommen2025,
author = {Oommen, Prasad T and Kallinich, Tilmann and Rech, Juergen and Blank, Norbert and Weber-Arden, Julia and Kuemmerle-Deschner, Jasmin B},
title = {Long-Term Safety and Effectiveness of Canakinumab in Patients with MKD/HIDS: Interim Analysis of the RELIANCE Registry},
journal = {Rheumatology and Therapy},
year = {2025},
volume = {12},
number = {1},
pages = {137--155},
doi = {10.1007/s40744-024-00733-7}
}
EUVIMED